Penumbra (PEN) Non-Current Deffered Revenue (2015 - 2018)
Penumbra (PEN) posted quarterly Non-Current Deffered Revenue of $7.6 million for Q4 2018, up 22.37% year-over-year from $6.2 million in Q4 2017, and up 1.01% quarter-over-quarter from $7.5 million in Q3 2018.
Penumbra (PEN) Non-Current Deffered Revenue (2015 - 2018) Analysis & Trends
Penumbra (PEN) has reported Non-Current Deffered Revenue for 4 consecutive years, with $7.6 million the latest figure, recorded in Q4 2018.
- In Q4 2018, Non-Current Deffered Revenue rose 22.37% year-over-year to $7.6 million; the TTM figure through Dec 2018 stood at $7.6 million (up 22.37% YoY), while the FY2018 annual figure was $7.6 million, up 22.37% from the prior year.
- Non-Current Deffered Revenue climbed to $7.6 million in Q4 2018 per PEN's latest filing, from $7.5 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $7.6 million in Q4 2018 and bottomed at $1.5 million in Q4 2015.
- Historically, Non-Current Deffered Revenue has averaged $6.0 million across 4 years, with a median of $6.1 million in 2017.
- Annual changes were most pronounced in 2016 — Non-Current Deffered Revenue surged 236.4% — and 2017, when it rose 21.96%.
- Penumbra's Non-Current Deffered Revenue stood at $1.5 million in 2015, then soared by 236.4% to $5.1 million in 2016, then advanced by 21.96% to $6.2 million in 2017, then grew by 22.37% to $7.6 million in 2018.
- Business Quant data shows PEN's Non-Current Deffered Revenue at $7.6 million in Q4 2018, $7.5 million in Q3 2018, and $7.4 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Penumbra | 12.76 Bn | 12.10 Bn | 264.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 7.59 Mn |
| Sep 30, 2018 | 7.51 Mn |
| Jun 30, 2018 | 7.43 Mn |
| Mar 31, 2018 | 7.35 Mn |
| Dec 31, 2017 | 6.20 Mn |
| Sep 30, 2017 | 6.07 Mn |
| Jun 30, 2017 | 5.68 Mn |
| Mar 31, 2017 | 5.50 Mn |
| Dec 31, 2016 | 5.08 Mn |
| Dec 31, 2015 | 1.51 Mn |